Ophthotech Corp (NASDAQ:OPHT)

50.02
Delayed Data
As of May 29
 +0.88 / +1.79%
Today’s Change
35.38
Today|||52-Week Range
58.29
+11.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.7B

Company Description

Ophthotech Corp. operates as a biopharmaceutical company. It focuses on discovering, developing and commercializing novel therapeutics to treat diseases of the eye. The company develops therapies for age-related macular degeneration. Its product candidates include Fovista Anti platelet derived growth factor Therapy, Zimura Anti-Complement and Aptamer Technology. The company was founded on January 5, 2007 by David R. Guyer and Samir Chandrakant Patel and is headquartered in New York, NY.

Contact Information

Ophthotech Corp.
One Penn Plaza
New York New York 10119
P:(212) 845-8200
Investor Relations:
(212) 845-8231

Employees

Shareholders

Mutual fund holders38.89%
Individual stakeholders37.93%
Other institutional25.23%

Top Executives

David R. GuyerChairman & Chief Executive Officer
Samir Chandrakant PatelVice Chairman & President
Evelyn M. HarrisonChief Operating Officer
Michael G. AtiehTreasurer, EVP, Chief Financial & Business Officer
Kourous A. RezaeiChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account